Hyperpolarized Carbon Metabolic Imaging in Multiple Sclerosis | MicrobiomeTrials← Back to trialsNCT07510607
Hyperpolarized Carbon Metabolic Imaging in Multiple Sclerosis
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-06-03Est. Completion: 2029-12-01
Enrollment target: 40 participants Locations- Byers Hall, San Francisco, California, United States
Other microbiome trials you might be interested in
Multiple SclerosisNeuromyelitis OpticaDemyelinating Diseases of the Central Nervous SystemMyelin Oligodendrocyte Glycoprotein Antibody-associated DiseaseClinically Isolated SyndromeRadiologically Isolated Syndrome
The Italian Multiple Sclerosis and Related Disorders Register (Registro Italiano Sclerosi Multipla e Patologie Correlate…
Genova, ItalyCompleted Jul 2026
Muscular Atrophy, Spinal
In this study, researchers will learn more about the effects and safety of BIIB115, also known as salanersen.
Specifica…
Chicago, United StatesEst. completion Nov 28, 2028
Relapsing Multiple Sclerosis
This open label, single arm study will evaluate the PK and PD effects of fenebrutinib in children and adolescents with R…
Rosario, ArgentinaEst. completion Jun 8, 2027